Anesthesia and Intensive Care Fondazione IRCCS Policlinico San Matteo Pavia Italy

Department of Anesthesiology and Intensive Care 1st Faculty of Medicine Charles University and General University Hospital Prague Prague Czechia

Department of Clinical Surgical Diagnostic and Pediatric Sciences University of Pavia Pavia Italy

Medical Intensive Care Unit Amiens University Hospital Amiens France

Zobrazit více v PubMed

Rehberg S, Frank S, Černý V, Cihlář R, Borgstedt R, Biancofiore G et al (2024) Landiolol for heart rate control in patients with septic shock and persistent tachycardia. A multicenter randomized clinical trial (Landi-SEP). Intensive Care Med 50(10):1622–1634 PubMed DOI PMC

Levy B, Slama M, Lakbar I, Maizel J, Kato H, Leone M, Okada M (2024) Landiolol for treatment of new-onset atrial fibrillation in critical care: a systematic review. J Clin Med 13(10):2951 PubMed DOI PMC

Kakihana Y, Nishida O, Taniguchi T, Okajima M, Morimatsu H, Ogura H et al (2020) Efficacy and safety of landiolol, an ultra-short-acting β1-selective antagonist, for treatment of sepsis-related tachyarrhythmia (J-Land 3S): a multicentre, open-label, randomised controlled trial. Lancet Respir Med 8(9):863–872 PubMed DOI

Balik M, Maly M, Brozek T, Rulisek J, Porizka M, Sachl R et al (2023) Propafenone versus amiodarone for supraventricular arrhythmias in septic shock: a randomised controlled trial. Intensive Care Med 49(11):1283–1292 PubMed DOI

Waldauf P, Porizka M, Horejsek J, Otahal M, Svobodova E, Jurisinova I et al (2024) The outcomes of patients with septic shock treated with propafenone compared to amiodarone for supraventricular arrhythmias are related to end-systolic left atrial volume. Eur Heart J Acute Cardiovasc Care 13(5):414–422 PubMed